MedTrace Logo

Cardiac Arrhythmias and Sudden Death in Patients Affected With Laminopathies

NCT02601066 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-04-06

No results posted yet for this study

Summary

This research study includes patients ages 1 to 25 years old with Lamin A/C related muscular dystrophy (LMNA-MD). The goal of this study is to evaluate how the heart is affected in children and teens with LMNA-MD. The evaluation includes an echocardiogram, an electrocardiogram, an electrophysiological study and the implantation of a subcutaneous ECG holter monitor.

Conditions

  • Cardiomyopathy Associated With Myopathy and Sudden Death

Interventions

DEVICE

Electrophysiological Study and ECG holter monitor

Electrophysiological Study and ECG holter monitor implantation

Sponsors & Collaborators

  • Marcio Andres Foundation

    collaborator OTHER

  • Hospital Sant Joan de Deu

    lead OTHER

Principal Investigators

  • Georgia Sarquella-Brugada, MD, PhD · Hospital Sant Joan de Deu

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2018-12-31
Completion
2019-09-30

Countries

  • Spain

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02601066 on ClinicalTrials.gov